Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Liver Dysfunction

gefitinib has been researched along with Liver Dysfunction in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, J; Fujio, Y; Furukawa, M; Imamura, F; Kijima, T; Komuta, K; Kumanogoh, A; Minami, S; Mori, M; Namba, Y; Nonen, S; Otani, Y; Tachibana, I; Takimoto, T; Tsuruta, N; Uchida, J; Yokota, S1
Cheng, NS; Li, FY; Ma, WJ; Mao, H; Shrestha, A; Yang, Q; Zhang, W; Zhou, Y1
Atobe, O; Fujimori, A; Hachiya, T; Ikuyama, Y; Imai, A; Shiba, H; Sonehara, K1
Cantarini, M; Carmichael, J; Harris, AL; Holt, A; Horak, J; Macpherson, M; Swaisland, A; Swaisland, H; Twelves, C; Verrill, M; White, J1
Furubo, S; Harada, K; Isse, K; Kizawa, K; Nakanuma, Y; Ozaki, S; Sanzen, T; Sasaki, M; Sato, Y; Yasoshima, M1

Other Studies

5 other study(ies) available for gefitinib and Liver Dysfunction

ArticleYear
Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity.
    Clinical lung cancer, 2013, Volume: 14, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Cytochrome P-450 CYP2D6; Female; Follow-Up Studies; Gefitinib; Humans; Liver Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Polymorphism, Genetic; Prognosis; Protein Kinase Inhibitors; Quinazolines

2013
Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2015, Volume: 14, Issue:5

    Topics: Adult; Aged; Bile Ducts; Cholangitis; Collagen Type I; Endoscopy, Digestive System; Epithelium; ErbB Receptors; Female; Gefitinib; Gene Expression; Glucuronidase; Humans; Hyperplasia; Ki-67 Antigen; Lithiasis; Liver Diseases; Male; Middle Aged; Mucin-3; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Quinazolines

2015
[Successful Treatment of Non-Small Cell Lung Cancer with Afatinib after Gefitinib-Induced Hepatotoxicity].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:1

    Topics: Afatinib; Aged; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Gefitinib; Humans; Liver Diseases; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines

2016
The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:6

    Topics: Adult; Antineoplastic Agents; Area Under Curve; Female; Gefitinib; Humans; Liver Diseases; Male; Middle Aged; Quinazolines

2011
Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
    The American journal of pathology, 2006, Volume: 169, Issue:4

    Topics: Animals; Bile Ducts, Intrahepatic; Dilatation, Pathologic; Disease Models, Animal; ErbB Receptors; Gefitinib; Liver; Liver Diseases; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Quinazolines; Rats

2006